UCSF Rosacea Study (Intendis/Bayer Aza 15%)

Introduction: This is a Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel-Group Clinical Trial to assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 weeks. You are being asked to participate in the screening for this study because you may have Papulopustular Rosacea with associated redness. This study is being conducted by Dr. Martin Steinhoff, at the University of California, San Francisco. The length of the study is about 16 weeks. After the screen visit, if you qualify, there are 12 weeks of twice daily treatment with the drug being tested, followed by a 4 week follow up period. There are a total of 6 study visits and it pays up to $180, if you are eligible and enroll in the study. Would you like to see if you might be eligible to participate in this study? The questionnaire should take about 5 or 10 minutes. Information collected during this telephone call will be retained whether you are eligible for the study or not.
* Required


Never submit passwords through Google Forms.